Mercaptamine Other names: Cysteamine

Chemical formula: C₂H₇NS Molecular mass: 77.149 g/mol PubChem compound: 6058

Therapeutic indications

Mercaptamine is indicated for:

Cystinosis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Mercaptamine is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

1 drop in each eye, 4 times a day during waking hours

Nephropathic cystinosis

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Mercaptamine is indicated for the treatment of proven nephropathic cystinosis. Cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

For patients up to age 12 years 1.30 g/m²/day of the free base divided 4 times daily and for patients over age 12 and 50 kg weight 2 g/day, divided 4 times daily

Contraindications

Mercaptamine is contraindicated in the following cases:

Lactation

Hypersensitivity to penicillamine

at least one of

Penicillamine allergy
Penicillamine adverse reaction

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.